These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7205484

  • 1. Plasma 17 alpha-hydroxyprogesterone and aldosterone concentrations in infants and children with congenital adrenal hyperplasia--the role of salt-losing hormones in salt wasting.
    Holcombe JH, Keenan BS, Clayton GW.
    J Pediatr; 1981 Apr; 98(4):573-5. PubMed ID: 7205484
    [No Abstract] [Full Text] [Related]

  • 2. Is salt-wasting in congenital adrenal hyperplasia due to the same gene as the fasciculata defect?
    Stoner E, Dimartino-Nardi J, Kuhnle U, Levine LS, Oberfield SE, New MI.
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):9-20. PubMed ID: 3486728
    [Abstract] [Full Text] [Related]

  • 3. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
    Sólyom J.
    Arch Dis Child; 1984 Aug; 59(8):743-7. PubMed ID: 6541026
    [Abstract] [Full Text] [Related]

  • 4. Plasma 17-hydroxyprogesterone in newborn infants with congenital adrenal hyperplasia and in infants with normal adrenal function.
    Atherden SM, Edmunds AT, Grant DB.
    Arch Dis Child; 1974 Mar; 49(3):192-4. PubMed ID: 4825623
    [Abstract] [Full Text] [Related]

  • 5. Plasma aldosterone concentrations related to 17alpha-hydroxyprogesterone in congenital adrenal hyperplasia.
    Pham-Huu-Trung MT, Raux MC, Gourmelen M, Baron MC, Girard F.
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):572-86. PubMed ID: 180741
    [Abstract] [Full Text] [Related]

  • 6. Plasma renin activity in the management of congenital adrenal hyperplasia.
    Griffiths KD, Anderson JM, Rudd BT, Virdi NK, Holder G, Rayner PH.
    Arch Dis Child; 1984 Apr; 59(4):360-5. PubMed ID: 6372706
    [Abstract] [Full Text] [Related]

  • 7. Congenital adrenal hyperplasia: simultaneous determination of plasma aldosterone and 17-hydroxyprogesterone.
    Parth K, Zimprich H, Swoboda W, Brunel R, Bohrn E.
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):148-57. PubMed ID: 202131
    [No Abstract] [Full Text] [Related]

  • 8. Persistence of the enzymatic block in adolescent patients with salt-losing congenital adrenal hyperplasia.
    Edwin C, Lanes R, Migeon CJ, Lee PA, Plotnick LP, Kowarski AA.
    J Pediatr; 1979 Oct; 95(4):534-7. PubMed ID: 314501
    [No Abstract] [Full Text] [Related]

  • 9. Value of selective screening for congenital adrenal hyperplasia in Hungary.
    Sólyom J, Hughes IA.
    Arch Dis Child; 1989 Mar; 64(3):338-42. PubMed ID: 2705794
    [Abstract] [Full Text] [Related]

  • 10. Plasma 17-hydroxyprogesterone concentrations in ill newborn infants.
    Murphy JF, Joyce BG, Dyas J, Hughes IA.
    Arch Dis Child; 1983 Jul; 58(7):532-4. PubMed ID: 6870334
    [Abstract] [Full Text] [Related]

  • 11. [The 17-hydroxyprogesterone blood test in newborn and young infants with congenital adrenal hyperplasia].
    Sólyom J, Babosa M, Dizséri T, Galambosi L, Hervei S, Marossy P, Sólyom E, Vágvölgyi E.
    Orv Hetil; 1982 Jan 17; 123(3):139-45. PubMed ID: 7063230
    [No Abstract] [Full Text] [Related]

  • 12. Serum 3 alpha-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia.
    Hatun S, Yordam N, Calikoğlu AS.
    Eur J Endocrinol; 1994 Nov 17; 131(5):504-8. PubMed ID: 7952161
    [Abstract] [Full Text] [Related]

  • 13. [Therapeutic monitoring in congenital adrenal hyperplasia using C.I.S. 17-alpha-hydroxyprogesterone radioimmunoassay kit (author's transl)].
    Nakajima F, Machida Y, Amano T, Oya N, Sawada J.
    Horumon To Rinsho; 1980 Nov 17; 28(5):601-5. PubMed ID: 7389169
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone.
    Barnes ND, Atherden SM.
    Arch Dis Child; 1972 Feb 17; 47(251):62-5. PubMed ID: 4336233
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Plasma 17-alpha-hydroxyprogesterone concentration for the diagnosis of congenital adrenal hyperplasia (author's transl)].
    Dumić M, Kalafatić Z, Tajić M, Gjurić G, Mardesić D.
    Lijec Vjesn; 1980 Feb 17; 102(7-8):400-3. PubMed ID: 7289713
    [No Abstract] [Full Text] [Related]

  • 18. Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol.
    Limal JM, Rappaport R, Bayard F.
    J Clin Endocrinol Metab; 1977 Sep 17; 45(3):551-9. PubMed ID: 198427
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Nimkarn S, Lin-Su K, Berglind N, Wilson RC, New MI.
    J Clin Endocrinol Metab; 2007 Jan 17; 92(1):137-42. PubMed ID: 17032723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.